Teleretinal Screening Program

Original Investigation Research

Disclaimer: The views expressed here are those of the authors and do not necessarily reflect the position or policy of the US Department of Veterans Affairs or the US government. Additional Contributions: Paul B. Greenberg, MD, Department of Surgery (Ophthalmology), Alpert Medical School of Brown University, and Providence Veterans Affairs Medical Center, Providence, Rhode Island, provided editorial assistance. REFERENCES 1. Veterans Health Administration. VHA Support Service Center [database online]. Austin, TX: Veterans Health Administration. http://vssc.med .va.gov. Accessed December 12, 2012. 2. Hunt RJ. Percent agreement, Pearson’s correlation, and kappa as measures of inter-examiner reliability. J Dent Res. 1986;65(2):128-130. 3. American Academy of Ophthalmology Retina Panel. Preferred Practice Pattern® Guidelines: Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology; 2008.

4. IBM Corp. IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp; 2012.

detecting and grading diabetic retinopathy. Diabetes Care. 2002;25(8):1384-1389.

5. Jones S, Edwards RT. Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med. 2010;27(3):249-256.

10. Kerr D, Cavan DA, Jennings B, Dunnington C, Gold D, Crick M. Beyond retinal screening: digital imaging in the assessment and follow-up of patients with diabetic retinopathy. Diabet Med. 1998;15(10):878-882.

6. Whited JD, Datta SK, Aiello LM, et al. A modeled economic analysis of a digital tele-ophthalmology system as used by three federal health care agencies for detecting proliferative diabetic retinopathy. Telemed J E Health. 2005;11(6):641-651. 7. Javitt JC, Aiello LP, Chiang Y, Ferris FL III, Canner JK, Greenfield S. Preventive eye care in people with diabetes is cost-saving to the federal government: implications for health-care reform. Diabetes Care. 1994;17(8):909-917. 8. Cavallerano AA, Cavallerano JD, Katalinic P, Tolson AM, Aiello LP, Aiello LM; Joslin Vision Network Clinical Team. Use of Joslin Vision Network digital-video nonmydriatic retinal imaging to assess diabetic retinopathy in a clinical program. Retina. 2003;23(2):215-223.

11. Bragge P, Gruen RL, Chau M, Forbes A, Taylor HR. Screening for presence or absence of diabetic retinopathy: a meta-analysis. Arch Ophthalmol. 2011;129(4):435-444. 12. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care. 1998;21(1):143-156. 13. Orcutt J, Avakian A, Koepsell TD, Maynard C. Eye disease in veterans with diabetes. Diabetes Care. 2004;27(suppl 2):B50-B53. 14. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology. 1991;98(5)(suppl):766-785.

9. Gómez-Ulla F, Fernandez MI, Gonzalez F, et al. Digital retinal images and teleophthalmology for

OPHTHALMIC IMAGES

Acquired Trichomegaly Trichomegaly Secondary to Erlotinib Carlos A. Medina Mendez, MD; Patrick C. Ma, MD; Arun D. Singh, MD A

B

Front (A) and lateral (B) external photographs of a woman in her early 60s who had undergone treatment with erlotinib for more than 2 and a half years. She developed bilateral trichomegaly, which required constant trimming.

jamaophthalmology.com

JAMA Ophthalmology September 2014 Volume 132, Number 9

Copyright 2014 American Medical Association. All rights reserved.

Downloaded From: by a University of Florida User on 12/10/2017

1051

Acquired trichomegaly: trichomegaly secondary to erlotinib.

Acquired trichomegaly: trichomegaly secondary to erlotinib. - PDF Download Free
111KB Sizes 0 Downloads 12 Views